An interesting possibility that is consistent with this is that in ccRCC the risk allele acts by increasing BHLHE41 expression and restricting anti-tumorigenic effects of HIF-1α at an early-stage in ccRCC development[15,18]. The gene discussed is HIF1A; the disease is nonpapillary renal cell carcinoma.